A Double-Blind, Placebo-Controlled, Randomized Phase II Pilot Study to Investigate the Potential Efficacy of the Traditional Chinese Medicine Neuroaid (MLC 601) in Enhancing Recovery after Stroke (TIERS)

By  

Cerebrovascular Diseases, Vol. 28, Iss. 5, 2009-10 ,pp. : 514-521

Karger

Access to resources Recommend Favorite

A Double-Blind, Placebo-Controlled, Ascending-Dose, Randomized Study to Evaluate the Safety, Tolerability and Effects on Cognition of AL-108 after 12 Weeks of Intranasal Administration in Subjects with Mild Cognitive Impairment

By  

Dementia and Geriatric Cognitive Disorders, Vol. 35, Iss. 5-6, 2013-04 ,pp. : 325-339

Karger

Access to resources Recommend Favorite

A double-blind, placebo-controlled, randomized study to evaluate the efficacy, safety and tolerability of tegaserod in patients with irritable bowel syndrome

By Nyhlin H.   Bang C.   Elsborg L.   Silvennoinen J.   Holme I.   Rüegg P.   Jones J.   Wagner A.  

Scandinavian Journal of Gastroenterology, Vol. 39, Iss. 2, 2004-02 ,pp. : 119-126

Informa Healthcare

Access to resources Recommend Favorite

A double-blind, randomized, placebo-controlled study of efficacy and tolerance of meloxicam treatment in patients with osteoarthritis of the knee

By Lund B.   Distel M.   Bluhmki E.  

Scandinavian Journal of Rheumatology, Vol. 27, Iss. 1, 1998-05 ,pp. : 32-37

Informa Healthcare

Access to resources Recommend Favorite

A Placebo-Controlled Double-Blind Randomized Study of Venlafaxine in the Treatment of Depression in Dementia

By  

Dementia and Geriatric Cognitive Disorders, Vol. 24, Iss. 1, 2007-05 ,pp. : 36-41

Karger

Access to resources Recommend Favorite